These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 23300447)
1. An Epstein-Barr virus encoded inhibitor of Colony Stimulating Factor-1 signaling is an important determinant for acute and persistent EBV infection. Ohashi M; Fogg MH; Orlova N; Quink C; Wang F PLoS Pathog; 2012 Dec; 8(12):e1003095. PubMed ID: 23300447 [TBL] [Abstract][Full Text] [Related]
2. Antibodies to lytic infection proteins in lymphocryptovirus-infected rhesus macaques: a model for humoral immune responses to epstein-barr virus infection. Orlova N; Fogg MH; Carville A; Wang F Clin Vaccine Immunol; 2011 Sep; 18(9):1427-34. PubMed ID: 21734064 [TBL] [Abstract][Full Text] [Related]
3. Cloning of the Epstein-Barr virus-related rhesus lymphocryptovirus as a bacterial artificial chromosome: a loss-of-function mutation of the rhBARF1 immune evasion gene. Ohashi M; Orlova N; Quink C; Wang F J Virol; 2011 Feb; 85(3):1330-9. PubMed ID: 21084476 [TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr Virus gp350 Can Functionally Replace the Rhesus Lymphocryptovirus Major Membrane Glycoprotein and Does Not Restrict Infection of Rhesus Macaques. Herrman M; Mühe J; Quink C; Wang F J Virol; 2016 Feb; 90(3):1222-30. PubMed ID: 26559839 [TBL] [Abstract][Full Text] [Related]
5. Soluble rhesus lymphocryptovirus gp350 protects against infection and reduces viral loads in animals that become infected with virus after challenge. Sashihara J; Hoshino Y; Bowman JJ; Krogmann T; Burbelo PD; Coffield VM; Kamrud K; Cohen JI PLoS Pathog; 2011 Oct; 7(10):e1002308. PubMed ID: 22028652 [TBL] [Abstract][Full Text] [Related]
6. The CD8+ T-cell response to an Epstein-Barr virus-related gammaherpesvirus infecting rhesus macaques provides evidence for immune evasion by the EBNA-1 homologue. Fogg MH; Kaur A; Cho YG; Wang F J Virol; 2005 Oct; 79(20):12681-91. PubMed ID: 16188971 [TBL] [Abstract][Full Text] [Related]
7. Persistent infection drives the development of CD8+ T cells specific for late lytic infection antigens in lymphocryptovirus-infected macaques and Epstein-Barr virus-infected humans. Orlova N; Wang F; Fogg MH J Virol; 2011 Dec; 85(23):12821-4. PubMed ID: 21917961 [TBL] [Abstract][Full Text] [Related]
8. Cloning of the rhesus lymphocryptovirus viral capsid antigen and Epstein-Barr virus-encoded small RNA homologues and use in diagnosis of acute and persistent infections. Rao P; Jiang H; Wang F J Clin Microbiol; 2000 Sep; 38(9):3219-25. PubMed ID: 10970361 [TBL] [Abstract][Full Text] [Related]
9. The BZLF1 homolog of an Epstein-Barr-related gamma-herpesvirus is a frequent target of the CTL response in persistently infected rhesus macaques. Fogg MH; Garry D; Awad A; Wang F; Kaur A J Immunol; 2006 Mar; 176(6):3391-401. PubMed ID: 16517707 [TBL] [Abstract][Full Text] [Related]
10. Experimental rhesus lymphocryptovirus infection in immunosuppressed macaques: an animal model for Epstein-Barr virus pathogenesis in the immunosuppressed host. Rivailler P; Carville A; Kaur A; Rao P; Quink C; Kutok JL; Westmoreland S; Klumpp S; Simon M; Aster JC; Wang F Blood; 2004 Sep; 104(5):1482-9. PubMed ID: 15150077 [TBL] [Abstract][Full Text] [Related]
11. Vaccination with nanoparticles displaying gH/gL from Epstein-Barr virus elicits limited cross-protection against rhesus lymphocryptovirus. Edwards KR; Schmidt K; Homad LJ; Kher GM; Xu G; Rodrigues KA; Ben-Akiva E; Abbott J; Prlic M; Newell EW; De Rosa SC; Irvine DJ; Pancera M; McGuire AT Cell Rep Med; 2024 Jun; 5(6):101587. PubMed ID: 38781964 [TBL] [Abstract][Full Text] [Related]
12. A new animal model for Epstein-Barr virus pathogenesis. Wang F Curr Top Microbiol Immunol; 2001; 258():201-19. PubMed ID: 11443863 [No Abstract] [Full Text] [Related]
13. Non-human Primate Lymphocryptoviruses: Past, Present, and Future. Mühe J; Wang F Curr Top Microbiol Immunol; 2015; 391():385-405. PubMed ID: 26428382 [TBL] [Abstract][Full Text] [Related]
14. Adenovirus-based vaccines against rhesus lymphocryptovirus EBNA-1 induce expansion of specific CD8+ and CD4+ T cells in persistently infected rhesus macaques. Leskowitz R; Fogg MH; Zhou XY; Kaur A; Silveira EL; Villinger F; Lieberman PM; Wang F; Ertl HC J Virol; 2014 May; 88(9):4721-35. PubMed ID: 24522914 [TBL] [Abstract][Full Text] [Related]
15. CD4+ and CD8+ T-cell responses to latent antigen EBNA-1 and lytic antigen BZLF-1 during persistent lymphocryptovirus infection of rhesus macaques. Leskowitz RM; Zhou XY; Villinger F; Fogg MH; Kaur A; Lieberman PM; Wang F; Ertl HC J Virol; 2013 Aug; 87(15):8351-62. PubMed ID: 23698300 [TBL] [Abstract][Full Text] [Related]
16. An animal model for acute and persistent Epstein-Barr virus infection. Moghaddam A; Rosenzweig M; Lee-Parritz D; Annis B; Johnson RP; Wang F Science; 1997 Jun; 276(5321):2030-3. PubMed ID: 9197263 [TBL] [Abstract][Full Text] [Related]
17. Nonhuman primate models for Epstein-Barr virus infection. Wang F Curr Opin Virol; 2013 Jun; 3(3):233-7. PubMed ID: 23562212 [TBL] [Abstract][Full Text] [Related]
18. Molecular evidence for rhesus lymphocryptovirus infection of epithelial cells in immunosuppressed rhesus macaques. Kutok JL; Klumpp S; Simon M; MacKey JJ; Nguyen V; Middeldorp JM; Aster JC; Wang F J Virol; 2004 Apr; 78(7):3455-61. PubMed ID: 15016868 [TBL] [Abstract][Full Text] [Related]
19. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques. Blaschke S; Hannig H; Buske C; Kaup FJ; Hunsmann G; Bodemer W J Med Virol; 2001 Sep; 65(1):114-20. PubMed ID: 11505452 [TBL] [Abstract][Full Text] [Related]